Final results were announced from a phase 3 trial evaluating SP-102 (injectable dexamethasone sodium phosphate viscous gel) for the treatment of lumbosacral radicular pain, or sciatica.
The study, sponsored by digital musculoskeletal-care company SWORD Health, also found improvements in secondary measures like surgery intent and painkiller use.
The FDA has granted Fast Track designation to SP-102 (injectable dexamethasone sodium phosphate viscous gel) for the treatment of lumbosacral radicular pain, or sciatica.
Strong Opioids No Better for Pain After Surgery for Fracture empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.